Gemmer Asset Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Gemmer Asset Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,939	Closed	-$30K	–	1497
2021 Q2	$30K	Hold	1,939	–	–	﹤0.01%	416
2021 Q1	$28K	Hold	1,939	–	–	﹤0.01%	401
2020 Q4	$25K	Hold	1,939	–	–	﹤0.01%	390
2020 Q3	$19K	Hold	1,939	–	–	﹤0.01%	418
2020 Q2	$19K	Hold	1,939	–	–	﹤0.01%	403
2020 Q1	$18K	Buy	1,939 +1,705	+729%	+$8.46K	﹤0.01%	365
2019 Q4	$38K	Buy	234 +40	+21%	+$295	0.01%	247
2019 Q3	$32K	Hold	194	–	–	0.01%	271
2019 Q2	$31K	Hold	194	–	–	0.01%	272
2019 Q1	$32K	Hold	194	–	–	0.01%	278
2018 Q4	$28K	Sell	194 -121	-38%	-$2.66K	0.01%	265
2018 Q3	$55K	Hold	315	–	–	0.02%	168
2018 Q2	$56K	Sell	315 -70	-18%	-$1.66K	0.02%	168
2018 Q1	$68K	Sell	385 -561	-59%	-$16.4K	0.02%	155
2017 Q4	$185K	Buy	946 +752	+388%	+$23.3K	0.06%	87
2017 Q3	$37K	Buy	194 +168	+646%	+$5.2K	0.01%	220
2017 Q2	$1K	Buy	+26	New	+$205	﹤0.01%	1230

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Gemmer Asset Management's AVEO Position: Q3 2021 in Review

Gemmer Asset Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2021, closing a stake of 1,939 shares — an estimated $30K sold.

Gemmer Asset Management first reported a position in AVEO in Q2 2017 and held it in 17 quarters. The position peaked at $185K in Q4 2017. 52 funds tracked by Wall St. Rank hold AVEO as of Q3 2021.

Gemmer Asset Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Gemmer Asset Management sold 1,939 AVEO Pharmaceuticals, Inc. shares in Q3 2021, an estimated $30K.
Gemmer Asset Management first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2017 and held it in 17 quarters.
Gemmer Asset Management's AVEO Pharmaceuticals, Inc. position peaked at $185K in Q4 2017.
52 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2021.

Based on Gemmer Asset Management's 13F filing for Q3 2021, filed 19 Oct 2021.